We provide practicing oncologists, clinicians, and researchers with practice-changing knowledge that can be applied immediately. -Eric Van Cutsem, MD, PhD, Congress Chair
Barcelona, Spain (PRWEB) May 25, 2016
ESMO 18th World Congress on Gastrointestinal Cancer, the premier 4-day global event highlighting the most relevant developments in gastrointestinal (GI) malignancies will be an unparalleled educational experience for the 3,500+ healthcare professionals attending. Organized by Imedex, a global leader in education, the event will take place on 29 June – 2 July in Barcelona, Spain.
"Attendee interaction with industry-leaders, education, new data, and a focus on practical aspects such as translational data are what fuel this Congress's success," said Eric Van Cutsem, MD, PhD, Congress Chair. "We provide practicing oncologists, clinicians, and researchers with practice-changing knowledge that can be applied immediately."
As there are currently hundreds of ongoing phase III clinical trials, the field of GI malignancies is continuously evolving. The Scientific Committee has curated a phenomenal list of presenters and topics for this year's scientific agenda. Keynote lectures will address the ever-changing landscape with which healthcare professionals are faced.
“As a reflection of the superb quality rightly associated with ESMO´s premier World Congresses on Gastrointestinal Cancer, we can once again look forward to an exceptional duo of Keynotes. Adam J. Bass, MD will deliver genomic-driven insights into the complex biology of gastric cancer aimed at ultimately spurring the development of more powerful anti-cancer therapies, and Scott Kopetz, MD, PhD, FACP will further explore the role of BRAF in colon cancer biology with emphasis on potentiating current BRAF inhibitors through combinatorial strategies to overcome acquired resistance,” said Josep Tabernero, MD, PhD, Congress Vice Chair, ESMO President-elect.
Looking toward the future, Philippe Rouanet, MD’s keynote “Robotic Surgery: Is it Becoming a Reality in GI Cancer?” will showcase the technological future as it relates to this therapy area of oncology.
“We are excited to continue our relationship with ESMO and bring such a valuable annual experience to the global GI community” said Chris Bolwell, COO of Imedex. “This is the 18th year, and our longevity in the medical education field continues to strengthen the Congress.”
“ESMO World Congress on Gastrointestinal Cancer gives healthcare professionals and researchers tremendous updates and education from which to move forward in effectively treating patients with gastrointestinal cancers,” said Mario Dicato, MD, Congress Chair.
2016 marks the 18th annual Congress, and will be chaired by Mario Dicato, MD, Eric Van Cutsem, MD, PhD, and Josep Tabernero, MD, PhD. As in the past, the Congress will be certified and organized by Imedex, an industry leader in providing CME programs in live conference settings and online. Attendance is expected to push 3,500 this year, and will likely be the largest annual gathering thus far.
About Imedex
Imedex is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management. Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 100,000 live meeting attendees, since 2001, Imedex truly educates the global healthcare community. At Imedex, education is the best medicine®. For more information on Imedex visit http://www.imedex.com.
About ESMO, European Society for Medical Oncology
ESMO is the leading European professional organization for medical oncology. Comprising more than 13,000 oncology professionals from over 130 countries, we are the society of reference for oncology education and information. We are committed to supporting our members to develop and advance in a fast-evolving professional environment.
Founded in 1975, ESMO has European roots and a global reach: we welcome oncology professionals from around the world. We are a home for all oncology stakeholders, connecting professionals with diverse expertise and experience. Our educational and information resources support an integrated, multi-professional approach to cancer treatment. We seek to erase boundaries in cancer care as we pursue our mission across oncology, worldwide. http://www.esmo.org
About the Congress Chairs
Mario Dicato, MD
Congress Chair
Head of Internal Medicine and the Division of Hematology and Oncology
Luxembourg Medical Center
Head, Research Laboratory
Luxembourg Foundation for Research on Cancer and Blood Diseases
Luxembourg, Luxembourg
Eric Van Cutsem, MD, PhD
Congress Chair
Professor of Internal Medicine
University of Leuven
Head, Digestive Oncology Unit
University Hospital Gasthuisberg
Leuven, Belgium
Josep Tabernero, MD, PhD,
Congress Vice Chair
ESMO President-elect
Head, Medical Oncology Department
Vall d’Hebron University Hospital
Director of the Vall d’Hebron Institute of Oncology
Barcelona, Spain